Key facts
- 82% of adults with type 2 diabetes not on insulin improved blood glucose levels using CGM.
- The study examined the role of CGM in managing type 2 diabetes patients not on insulin.
- Findings suggest CGM's potential in primary care settings for diabetes management.
A recent study presented in New Orleans on June 6, 2026, has revealed significant improvements in blood glucose management for adults with type 2 diabetes who are not currently on insulin therapy. The research focused on the effectiveness of continuous glucose monitoring (CGM) devices in helping these patients achieve better control over their condition. According to the study's findings, an overwhelming 82% of participants who utilized CGM experienced an improvement in their blood glucose levels. This suggests that CGM technology could play a crucial role in enhancing diabetes management strategies within primary care settings, offering a more proactive approach to monitoring and intervention for a substantial portion of the type 2 diabetes population.